Home > Journals > Chirurgia > Past Issues > Chirurgia 2007 October;20(5) > Chirurgia 2007 October;20(5):277-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Chirurgia 2007 October;20(5):277-9

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Ductal carcinoma in situ. Surgical therapy: a mini review

Franceschini G., Terribile D., Magno S., Fabbri C., D’Alba P., Chiesa F., Di Leone A., Masetti R.

Breast Surgery Unit Policlinico Agostino Gemelli Catholic University School of Medicine, Rome, Italy


PDF


The incidence of ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer, has increased markedly in recent decades, and DCIS now accounts for approximately 20% of breast cancers diagnosed by mammography. Laboratory and patient data suggest that DCIS is a precursor lesion for invasive cancer. The appropriate classification of DCIS has provoked much debate; a number of classification systems have been developed, but there is a lack of uniformity in the diagnosis and prognostication of this disease. Further investigation of molecular markers should improve the classification of DCIS and our understanding of its relationship to invasive disease. Controversy also exists with regard to the optimal management of DCIS patients. In the past, mastectomy was the primary treatment for patients with DCIS, but as with invasive cancer, breast-conserving surgery has become the standard approach. A mini-review of the management of ductal carcinoma in situ is presented, and the roles and dilemmas of surgery, radiotherapy and endocrine therapy are discussed.

top of page